Global Artificial Sperm Market Size, Share & Trends Analysis Report, Forecast Period, 2023-2030
Report ID: MS-1437 | Healthcare and Pharma | Last updated: Jul, 2024 | Formats*:
Description
Table of content
Market Segments
The Artificial Sperm market is experiencing robust expansion, with market size projected to increase from XX billion in 2024 to
xx billion by 2030, demonstrating a consistent year-over-year growth rate of 8.7%. Artificial Sperm Market Size, Share, Competitive Landscape and Trend Analysis Report, by Types (Chemical Sperm Substitute, Biological Sperm Substitute), by applications (Fertility Treatment, Research and Development, Livestock and Agricultural) And regions (North America(United States.Canada.Mexico), South America(Brazil.Argentina.Chile.Rest of South America), Europe(Germany.France.Italy.United Kingdom.Benelux.Nordics.Rest of Europe), Asia Pacific(China.Japan.India.South Korea.Australia.Southeast Asia.Rest of Asia-Pacific), MEA(Middle East.Africa)) : Industry Forecast and Opportunity Analysis for 2024 - 2030
Sperm Bank Market: Representing the existing market for donated sperm used in fertility
treatments, sperm banks collect, screen, and then store sperm from donors for use in
procedures like IUI or IVF.
Artificial Sperm Report Highlights
Report Metrics | Details |
---|---|
Forecast period | 2019-2030 |
Base Year Of Estimation | 2023 |
Growth Rate | CAGR of 8.7% |
By Product Type | Chemical Sperm Substitute, Biological Sperm Substitute |
Key Market Players |
|
By Region |
|
Artificial Sperm Market Trends
Trends: • Genetic Counselling: Most sperm banks advise genetic counselling for both donors and recipients to understand its implications on their health. • Reproductive tourism: These countries that have more lenient regulations regarding fertility treatment and at comparable economical costs have increased travel for sperm donation services. • Thus, it will result in a cost reduction since, with new players entering the market, the pricing of sperm donation services is made a little more competitive. • Increased awareness: Informed and open communication about fertility issues and sperm donation will influence more people to consider the options, hence less stigmatised.Artificial Sperm Market Leading Players
The key players profiled in the report are ABS Global, Alta Genetics, Cogent, Genus, Kallistem, Nerging Medical University and Institute of Zoology, others, Select Sires, SEMEX, ST Genetics, Swine Genetics, the Chinese Academy of Sciences, Trans Ova Genetics, University of California San Diego School of Medicine, Viking Genetics, Xcell Breeding and Livestock Services, Ziva FertilityArtificial Sperm Market Segmentation analysis
The Global Artificial Sperm is segmented by Type, Application, and Region. By Type, the market is divided into Distributed Chemical Sperm Substitute, Biological Sperm Substitute . The Application segment categorizes the market based on its usage such as Fertility Treatment, Research and Development, Livestock and Agricultural. Geographically, the market is assessed across key Regions like North America(United States.Canada.Mexico), South America(Brazil.Argentina.Chile.Rest of South America), Europe(Germany.France.Italy.United Kingdom.Benelux.Nordics.Rest of Europe), Asia Pacific(China.Japan.India.South Korea.Australia.Southeast Asia.Rest of Asia-Pacific), MEA(Middle East.Africa) and others, each presenting distinct growth opportunities and challenges influenced by the regions.Challenges In Artificial Sperm Market
• Stricter Regulations: Many governments across the world have rules over sperm donation. This may be in donors' anonymity, screening methods, and maintaining the records of the same. While strict regulations do assure safety most of the time, it becomes rather challenging to maintain a sperm bank and, at times, even limit availability in some places. • High Costs: Involvement in methods of screening, processing, storing, and insemination involve a high price while using a sperm bank. Well, this is quite inaccessible to many intended parents. • Availability and Variety of Donors: The donors may not be readily available in as much of a number as required, especially if some of them specify ethnicities or other traits. Moreover, diversity in donors to address the requirements of different families may also be hard to come by.Table of content
1: Introduction
2: Executive Summary
3: Market Overview
4: Artificial Sperm Market by Type
5: Artificial Sperm Market by Application / by End Use
6: Artificial Sperm Market by Technology
7: Artificial Sperm Market by End Users
8: Artificial Sperm Market by Region
10: Company Profiles
11: Analyst Perspective and Conclusion
- 1.1 Report description
- 1.2 Key market segments
- 1.3 Key benefits to the stakeholders
2: Executive Summary
- 2.1 Artificial Sperm- Snapshot
- 2.2 Artificial Sperm- Segment Snapshot
- 2.3 Artificial Sperm- Competitive Landscape Snapshot
3: Market Overview
- 3.1 Market definition and scope
- 3.2 Key findings
- 3.2.1 Top impacting factors
- 3.2.2 Top investment pockets
- 3.3 Porter’s five forces analysis
- 3.3.1 Low bargaining power of suppliers
- 3.3.2 Low threat of new entrants
- 3.3.3 Low threat of substitutes
- 3.3.4 Low intensity of rivalry
- 3.3.5 Low bargaining power of buyers
- 3.4 Market dynamics
- 3.4.1 Drivers
- 3.4.2 Restraints
- 3.4.3 Opportunities
4: Artificial Sperm Market by Type
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Chemical Sperm Substitute
- 4.2.1 Key market trends, factors driving growth, and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3 Biological Sperm Substitute
- 4.3.1 Key market trends, factors driving growth, and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
5: Artificial Sperm Market by Application / by End Use
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Fertility Treatment
- 5.2.1 Key market trends, factors driving growth, and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3 Research and Development
- 5.3.1 Key market trends, factors driving growth, and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
- 5.4 Livestock and Agricultural
- 5.4.1 Key market trends, factors driving growth, and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
6: Artificial Sperm Market by Technology
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Artificial Insemination
- 6.2.1 Key market trends, factors driving growth, and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
- 6.3 In Vitro-Fertilization
- 6.3.1 Key market trends, factors driving growth, and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
- 6.4 Others
- 6.4.1 Key market trends, factors driving growth, and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market share analysis by country
7: Artificial Sperm Market by End Users
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Hospitals and Clinics
- 7.2.1 Key market trends, factors driving growth, and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market share analysis by country
- 7.3 Fertility Clinics and Centers
- 7.3.1 Key market trends, factors driving growth, and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market share analysis by country
- 7.4 Rehabilitation Centers
- 7.4.1 Key market trends, factors driving growth, and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market share analysis by country
- 7.5 Research Institutions
- 7.5.1 Key market trends, factors driving growth, and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market share analysis by country
- 7.6 Others
- 7.6.1 Key market trends, factors driving growth, and opportunities
- 7.6.2 Market size and forecast, by region
- 7.6.3 Market share analysis by country
8: Artificial Sperm Market by Region
- 8.1 Overview
- 8.1.1 Market size and forecast By Region
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 Market size and forecast, by Type
- 8.2.3 Market size and forecast, by Application
- 8.2.4 Market size and forecast, by country
- 8.2.4.1 United States
- 8.2.4.1.1 Key market trends, factors driving growth, and opportunities
- 8.2.4.1.2 Market size and forecast, by Type
- 8.2.4.1.3 Market size and forecast, by Application
- 8.2.4.2 Canada
- 8.2.4.2.1 Key market trends, factors driving growth, and opportunities
- 8.2.4.2.2 Market size and forecast, by Type
- 8.2.4.2.3 Market size and forecast, by Application
- 8.2.4.3 Mexico
- 8.2.4.3.1 Key market trends, factors driving growth, and opportunities
- 8.2.4.3.2 Market size and forecast, by Type
- 8.2.4.3.3 Market size and forecast, by Application
- 8.2.4.1 United States
- 8.3 South America
- 8.3.1 Key trends and opportunities
- 8.3.2 Market size and forecast, by Type
- 8.3.3 Market size and forecast, by Application
- 8.3.4 Market size and forecast, by country
- 8.3.4.1 Brazil
- 8.3.4.1.1 Key market trends, factors driving growth, and opportunities
- 8.3.4.1.2 Market size and forecast, by Type
- 8.3.4.1.3 Market size and forecast, by Application
- 8.3.4.2 Argentina
- 8.3.4.2.1 Key market trends, factors driving growth, and opportunities
- 8.3.4.2.2 Market size and forecast, by Type
- 8.3.4.2.3 Market size and forecast, by Application
- 8.3.4.3 Chile
- 8.3.4.3.1 Key market trends, factors driving growth, and opportunities
- 8.3.4.3.2 Market size and forecast, by Type
- 8.3.4.3.3 Market size and forecast, by Application
- 8.3.4.4 Rest of South America
- 8.3.4.4.1 Key market trends, factors driving growth, and opportunities
- 8.3.4.4.2 Market size and forecast, by Type
- 8.3.4.4.3 Market size and forecast, by Application
- 8.3.4.1 Brazil
- 8.4 Europe
- 8.4.1 Key trends and opportunities
- 8.4.2 Market size and forecast, by Type
- 8.4.3 Market size and forecast, by Application
- 8.4.4 Market size and forecast, by country
- 8.4.4.1 Germany
- 8.4.4.1.1 Key market trends, factors driving growth, and opportunities
- 8.4.4.1.2 Market size and forecast, by Type
- 8.4.4.1.3 Market size and forecast, by Application
- 8.4.4.2 France
- 8.4.4.2.1 Key market trends, factors driving growth, and opportunities
- 8.4.4.2.2 Market size and forecast, by Type
- 8.4.4.2.3 Market size and forecast, by Application
- 8.4.4.3 Italy
- 8.4.4.3.1 Key market trends, factors driving growth, and opportunities
- 8.4.4.3.2 Market size and forecast, by Type
- 8.4.4.3.3 Market size and forecast, by Application
- 8.4.4.4 United Kingdom
- 8.4.4.4.1 Key market trends, factors driving growth, and opportunities
- 8.4.4.4.2 Market size and forecast, by Type
- 8.4.4.4.3 Market size and forecast, by Application
- 8.4.4.5 Benelux
- 8.4.4.5.1 Key market trends, factors driving growth, and opportunities
- 8.4.4.5.2 Market size and forecast, by Type
- 8.4.4.5.3 Market size and forecast, by Application
- 8.4.4.6 Nordics
- 8.4.4.6.1 Key market trends, factors driving growth, and opportunities
- 8.4.4.6.2 Market size and forecast, by Type
- 8.4.4.6.3 Market size and forecast, by Application
- 8.4.4.7 Rest of Europe
- 8.4.4.7.1 Key market trends, factors driving growth, and opportunities
- 8.4.4.7.2 Market size and forecast, by Type
- 8.4.4.7.3 Market size and forecast, by Application
- 8.4.4.1 Germany
- 8.5 Asia Pacific
- 8.5.1 Key trends and opportunities
- 8.5.2 Market size and forecast, by Type
- 8.5.3 Market size and forecast, by Application
- 8.5.4 Market size and forecast, by country
- 8.5.4.1 China
- 8.5.4.1.1 Key market trends, factors driving growth, and opportunities
- 8.5.4.1.2 Market size and forecast, by Type
- 8.5.4.1.3 Market size and forecast, by Application
- 8.5.4.2 Japan
- 8.5.4.2.1 Key market trends, factors driving growth, and opportunities
- 8.5.4.2.2 Market size and forecast, by Type
- 8.5.4.2.3 Market size and forecast, by Application
- 8.5.4.3 India
- 8.5.4.3.1 Key market trends, factors driving growth, and opportunities
- 8.5.4.3.2 Market size and forecast, by Type
- 8.5.4.3.3 Market size and forecast, by Application
- 8.5.4.4 South Korea
- 8.5.4.4.1 Key market trends, factors driving growth, and opportunities
- 8.5.4.4.2 Market size and forecast, by Type
- 8.5.4.4.3 Market size and forecast, by Application
- 8.5.4.5 Australia
- 8.5.4.5.1 Key market trends, factors driving growth, and opportunities
- 8.5.4.5.2 Market size and forecast, by Type
- 8.5.4.5.3 Market size and forecast, by Application
- 8.5.4.6 Southeast Asia
- 8.5.4.6.1 Key market trends, factors driving growth, and opportunities
- 8.5.4.6.2 Market size and forecast, by Type
- 8.5.4.6.3 Market size and forecast, by Application
- 8.5.4.7 Rest of Asia-Pacific
- 8.5.4.7.1 Key market trends, factors driving growth, and opportunities
- 8.5.4.7.2 Market size and forecast, by Type
- 8.5.4.7.3 Market size and forecast, by Application
- 8.5.4.1 China
- 8.6 MEA
- 8.6.1 Key trends and opportunities
- 8.6.2 Market size and forecast, by Type
- 8.6.3 Market size and forecast, by Application
- 8.6.4 Market size and forecast, by country
- 8.6.4.1 Middle East
- 8.6.4.1.1 Key market trends, factors driving growth, and opportunities
- 8.6.4.1.2 Market size and forecast, by Type
- 8.6.4.1.3 Market size and forecast, by Application
- 8.6.4.2 Africa
- 8.6.4.2.1 Key market trends, factors driving growth, and opportunities
- 8.6.4.2.2 Market size and forecast, by Type
- 8.6.4.2.3 Market size and forecast, by Application
- 8.6.4.1 Middle East
- 9.1 Overview
- 9.2 Key Winning Strategies
- 9.3 Top 10 Players: Product Mapping
- 9.4 Competitive Analysis Dashboard
- 9.5 Market Competition Heatmap
- 9.6 Leading Player Positions, 2022
10: Company Profiles
- 10.1 ABS Global
- 10.1.1 Company Overview
- 10.1.2 Key Executives
- 10.1.3 Company snapshot
- 10.1.4 Active Business Divisions
- 10.1.5 Product portfolio
- 10.1.6 Business performance
- 10.1.7 Major Strategic Initiatives and Developments
- 10.2 Alta Genetics
- 10.2.1 Company Overview
- 10.2.2 Key Executives
- 10.2.3 Company snapshot
- 10.2.4 Active Business Divisions
- 10.2.5 Product portfolio
- 10.2.6 Business performance
- 10.2.7 Major Strategic Initiatives and Developments
- 10.3 Cogent
- 10.3.1 Company Overview
- 10.3.2 Key Executives
- 10.3.3 Company snapshot
- 10.3.4 Active Business Divisions
- 10.3.5 Product portfolio
- 10.3.6 Business performance
- 10.3.7 Major Strategic Initiatives and Developments
- 10.4 Genus
- 10.4.1 Company Overview
- 10.4.2 Key Executives
- 10.4.3 Company snapshot
- 10.4.4 Active Business Divisions
- 10.4.5 Product portfolio
- 10.4.6 Business performance
- 10.4.7 Major Strategic Initiatives and Developments
- 10.5 Kallistem
- 10.5.1 Company Overview
- 10.5.2 Key Executives
- 10.5.3 Company snapshot
- 10.5.4 Active Business Divisions
- 10.5.5 Product portfolio
- 10.5.6 Business performance
- 10.5.7 Major Strategic Initiatives and Developments
- 10.6 Nerging Medical University and Institute of Zoology
- 10.6.1 Company Overview
- 10.6.2 Key Executives
- 10.6.3 Company snapshot
- 10.6.4 Active Business Divisions
- 10.6.5 Product portfolio
- 10.6.6 Business performance
- 10.6.7 Major Strategic Initiatives and Developments
- 10.7 others
- 10.7.1 Company Overview
- 10.7.2 Key Executives
- 10.7.3 Company snapshot
- 10.7.4 Active Business Divisions
- 10.7.5 Product portfolio
- 10.7.6 Business performance
- 10.7.7 Major Strategic Initiatives and Developments
- 10.8 Select Sires
- 10.8.1 Company Overview
- 10.8.2 Key Executives
- 10.8.3 Company snapshot
- 10.8.4 Active Business Divisions
- 10.8.5 Product portfolio
- 10.8.6 Business performance
- 10.8.7 Major Strategic Initiatives and Developments
- 10.9 SEMEX
- 10.9.1 Company Overview
- 10.9.2 Key Executives
- 10.9.3 Company snapshot
- 10.9.4 Active Business Divisions
- 10.9.5 Product portfolio
- 10.9.6 Business performance
- 10.9.7 Major Strategic Initiatives and Developments
- 10.10 ST Genetics
- 10.10.1 Company Overview
- 10.10.2 Key Executives
- 10.10.3 Company snapshot
- 10.10.4 Active Business Divisions
- 10.10.5 Product portfolio
- 10.10.6 Business performance
- 10.10.7 Major Strategic Initiatives and Developments
- 10.11 Swine Genetics
- 10.11.1 Company Overview
- 10.11.2 Key Executives
- 10.11.3 Company snapshot
- 10.11.4 Active Business Divisions
- 10.11.5 Product portfolio
- 10.11.6 Business performance
- 10.11.7 Major Strategic Initiatives and Developments
- 10.12 the Chinese Academy of Sciences
- 10.12.1 Company Overview
- 10.12.2 Key Executives
- 10.12.3 Company snapshot
- 10.12.4 Active Business Divisions
- 10.12.5 Product portfolio
- 10.12.6 Business performance
- 10.12.7 Major Strategic Initiatives and Developments
- 10.13 Trans Ova Genetics
- 10.13.1 Company Overview
- 10.13.2 Key Executives
- 10.13.3 Company snapshot
- 10.13.4 Active Business Divisions
- 10.13.5 Product portfolio
- 10.13.6 Business performance
- 10.13.7 Major Strategic Initiatives and Developments
- 10.14 University of California San Diego School of Medicine
- 10.14.1 Company Overview
- 10.14.2 Key Executives
- 10.14.3 Company snapshot
- 10.14.4 Active Business Divisions
- 10.14.5 Product portfolio
- 10.14.6 Business performance
- 10.14.7 Major Strategic Initiatives and Developments
- 10.15 Viking Genetics
- 10.15.1 Company Overview
- 10.15.2 Key Executives
- 10.15.3 Company snapshot
- 10.15.4 Active Business Divisions
- 10.15.5 Product portfolio
- 10.15.6 Business performance
- 10.15.7 Major Strategic Initiatives and Developments
- 10.16 Xcell Breeding and Livestock Services
- 10.16.1 Company Overview
- 10.16.2 Key Executives
- 10.16.3 Company snapshot
- 10.16.4 Active Business Divisions
- 10.16.5 Product portfolio
- 10.16.6 Business performance
- 10.16.7 Major Strategic Initiatives and Developments
- 10.17 Ziva Fertility
- 10.17.1 Company Overview
- 10.17.2 Key Executives
- 10.17.3 Company snapshot
- 10.17.4 Active Business Divisions
- 10.17.5 Product portfolio
- 10.17.6 Business performance
- 10.17.7 Major Strategic Initiatives and Developments
11: Analyst Perspective and Conclusion
- 11.1 Concluding Recommendations and Analysis
- 11.2 Strategies for Market Potential
Scope of Report
Aspects | Details |
---|---|
By Type |
|
By Application |
|
By Technology |
|
By End Users |
|
Report Licenses
$3200
$4500
$5500